Singular Genomics Systems, Inc.
NASDAQ:OMIC
23.3 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 2.911 | 0.765 | 0 | 0 | 0 |
| Cost of Revenue
| 3.469 | 0.789 | 1.133 | 0.639 | 0.35 |
| Gross Profit
| -0.558 | -0.024 | -1.133 | -0.639 | -0.35 |
| Gross Profit Ratio
| -0.192 | -0.031 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 47.764 | 46.199 | 32.655 | 21.247 | 10.484 |
| General & Administrative Expenses
| 0 | 0 | 0 | 6.287 | 2.286 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 |
| SG&A
| 54.479 | 47.264 | 28.624 | 6.287 | 2.286 |
| Other Expenses
| 0 | 0 | 0.405 | 0 | 0 |
| Operating Expenses
| 102.243 | 93.463 | 61.279 | 27.534 | 12.77 |
| Operating Income
| -102.801 | -93.487 | -61.279 | -27.534 | -12.77 |
| Operating Income Ratio
| -35.315 | -122.205 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 7.981 | 2.608 | -37.492 | -0.411 | 0.446 |
| Income Before Tax
| -94.82 | -90.879 | -98.771 | -27.945 | -12.324 |
| Income Before Tax Ratio
| -32.573 | -118.796 | 0 | 0 | 0 |
| Income Tax Expense
| 9.082 | -2.608 | 0.118 | 0.718 | 0.017 |
| Net Income
| -94.82 | -88.271 | -98.889 | -28.663 | -12.341 |
| Net Income Ratio
| -32.573 | -115.387 | 0 | 0 | 0 |
| EPS
| -39.08 | -37.22 | -40.95 | -12.41 | -5.34 |
| EPS Diluted
| -39.08 | -37.22 | -40.95 | -12.41 | -5.34 |
| EBITDA
| -86.496 | -90.116 | -60.546 | -26.39 | -11.957 |
| EBITDA Ratio
| -29.714 | -117.799 | 0 | 0 | 0 |